Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
Average yearly return: +47%
Insulet posted revenues of $226.30 million for the quarter ended June 2020. This compares to year-ago revenues of $177.14 million.
| Strong buy | |
| Buy | |
| X | Wait |
| Sell | |
| Strong sell |
If you found this site useful and want to help keep it alive,
to cover the costs and keep the site free of advertisements! Thank you for your support!
